๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus

โœ Scribed by Andrew P. Cairns; Alistair D. Crockard; Aubrey L. Bell

Publisher
Springer
Year
2002
Tongue
English
Weight
89 KB
Volume
21
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Levels of soluble fas/APO-1 /CD95 in sys
Levels of soluble fas/APO-1 /CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis
โœ Eckart Knipping; Peter H. Krammer; Karen B. Onel; Thomas J. A. Lehman; Eduardo M ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 304 KB ๐Ÿ‘ 2 views

To quantify soluble Fas/APO-1 (sFas/ APO-1) protein in the serum of patients with systemic lupus erythematosus (SLE) and juvenile rheumatoid arthritis (JRA). Methods. Soluble Fas/APO-1 was quantified using a sandwich enzyme-linked immunosorbent assay. Disease activity in SLE patients was assessed b

Frequency of neoplasia in systemic lupus
Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis
โœ Robert B. Lewis; C. William Castor; Robert E. Knisley; Giles G. Bole ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 410 KB ๐Ÿ‘ 3 views

## Abstract A patient population admitted to the hospital for either SLE or RA was surveyed for the subsequent development of neoplasms. The frequency of neoplasm in SLE patients appeared to be exaggerated, whereas the frequency of subsequent neoplasm in rheumatoid patients was unexpectedly low. A